Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, July 10, 2015, 32 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.66 to $45,667,114.90.

Highlighted Stocks Traded by Insiders:

JetBlue Airways (JBLU) - FREE Research Report

Peterson Joel Clinton, who is Director at JetBlue Airways, sold 10,981 shares at $20.75 on July 10, 2015. Following this transaction, the Director owned 647,895 shares meaning that the stake was reduced by 1.67% with the 10,981-share transaction.

The shares most recently traded at $22.00, up $1.25, or 5.67% since the insider transaction. Historical insider transactions for JetBlue Airways go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 56,614
  • 24-Week # shares sold: 98,614

The average volume for JetBlue Airways has been 9.7 million shares per day over the past 30 days. JetBlue Airways has a market cap of $6.5 billion and is part of the services sector and transportation industry. Shares are up 36.95% year-to-date as of the close of trading on Friday.

JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 13 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 EMBRAER 190 aircrafts. The company has a P/E ratio of 13.2. Currently, there are 9 analysts who rate JetBlue Airways a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBLU - FREE

TheStreet Quant Ratings

rates JetBlue Airways as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

JetBlue Airways Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Usana Health (USNA) - FREE Research Report

Gull Global Ltd, who is 10% Owner at Usana Health, sold 7,000 shares at $138.28 on July 10, 2015. Following this transaction, the 10% Owner owned 6.5 million shares meaning that the stake was reduced by 0.11% with the 7,000-share transaction.

The shares most recently traded at $138.69, up $0.41, or 0.3% since the insider transaction. Historical insider transactions for Usana Health go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 14,000
  • 24-Week # shares sold: 21,000

The average volume for Usana Health has been 110,400 shares per day over the past 30 days. Usana Health has a market cap of $1.7 billion and is part of the health care sector and drugs industry. Shares are up 31.75% year-to-date as of the close of trading on Friday.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease worldwide. The company has a P/E ratio of 25.3. Currently, there is 1 analyst who rates Usana Health a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USNA - FREE

TheStreet Quant Ratings

rates Usana Health as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Usana Health Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Calavo Growers (CVGW) - FREE Research Report

Brown Marc Laurence, who is Director at Calavo Growers, sold 1,000 shares at $51.85 on July 10, 2015. Following this transaction, the Director owned 7,882 shares meaning that the stake was reduced by 11.26% with the 1,000-share transaction.

The shares most recently traded at $52.17, up $0.32, or 0.61% since the insider transaction. Historical insider transactions for Calavo Growers go as follows:

  • 4-Week # shares sold: 232,196
  • 12-Week # shares sold: 261,838
  • 24-Week # shares sold: 261,838

The average volume for Calavo Growers has been 106,700 shares per day over the past 30 days. Calavo Growers has a market cap of $889.9 million and is part of the consumer goods sector and food & beverage industry. Shares are up 10.04% year-to-date as of the close of trading on Friday.

Calavo Growers, Inc. markets, and distributes avocados, prepared avocados, and other perishable foods to food distributors, produce wholesalers, supermarkets, convenience stores, and restaurants worldwide. It operates in three segments: Fresh Products, Calavo Foods, and RFG. The stock currently has a dividend yield of 1.47%. The company has a P/E ratio of 63.2. Currently, there is 1 analyst who rates Calavo Growers a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CVGW - FREE

TheStreet Quant Ratings

rates Calavo Growers as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Calavo Growers Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.